ES2040217T3 - Procedimiento para preparar derivados de acido flavona-carboxilico. - Google Patents

Procedimiento para preparar derivados de acido flavona-carboxilico.

Info

Publication number
ES2040217T3
ES2040217T3 ES198787103691T ES87103691T ES2040217T3 ES 2040217 T3 ES2040217 T3 ES 2040217T3 ES 198787103691 T ES198787103691 T ES 198787103691T ES 87103691 T ES87103691 T ES 87103691T ES 2040217 T3 ES2040217 T3 ES 2040217T3
Authority
ES
Spain
Prior art keywords
lower alkyl
hydrogen
iii
formula
flavona
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787103691T
Other languages
English (en)
Inventor
Koichi Prof. Shudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2040217T3 publication Critical patent/ES2040217T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

SE DESCRIBE UN DERIVADO DE ACIDO FLAVONOCARBOXILICO QUE ESTA REPRESENTADO POR LA FORMULA (III) EN LA QUE R1 Y R2, QUE PUEDEN SER IGUALES O DIFERENTES, REPRESENTA CADA UNA DE ELLAS HIDROGENO, ALQUILO INFERIOR, ESPECIALMENTE CON 3 A 4 CARBONOS, SIENDE POR LO MENOS UNA DE LAS R1 Y DE LAS R2 DISTINTA DE HIDROGENO, Y EN LA QUE AMBOS SUSTITUYENTES VECINOS R1 Y R2 PUEDEN COMBINARSE ENTRE SI OPCIONALMENTE CON UN ATOMO DE OXIGENO, NITROGENO O AZUFRE, PARA FORMAR UN CICLOALQUILO O HETEROCICLO DE 5 A 6 MIEMBROS, QUE ESTA PREFERIBLEMENTE SUSTITUIDO CON ALQUILO O ALQUILOS INFERIORES, R3 REPRESENTA HIDROGENO O ALQUILO INFERIOR Y R4 REPRESENTA HIDROGENO O HIDROXILO, ASI COMO COMPUESTOS INTERMEDIOS REPRESENTADOS POR LA FORMULA (IV) PARA PREPARAR LOS DERIVADOS DE ACIDO CARBOXILICO (III) ; R4 = H) ASI COMO EL COMPUESTO INTERMEDIO V PARA PREPARAR EL DERIVADO (III; R4 = OH). ADEMAS, SE DESCRIBE UNA DIFERENCIACION QUE INCLUYE UN AGENTE PARA LAS CELULAS NEOPLASICAS, ESPECIALMENTE LAS CELULAS LEUCEMICAS, QUECONTIENE COMO INGREDIENTE ACTIVO UNO O MAS COMPUESTOS DE ACIDO FLAVONOCARBOXILICO REPRESENTADOS POR LA FORMULA (III).
ES198787103691T 1986-03-18 1987-03-14 Procedimiento para preparar derivados de acido flavona-carboxilico. Expired - Lifetime ES2040217T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61059850A JPS62215581A (ja) 1986-03-18 1986-03-18 フラボンカルボン酸誘導体

Publications (1)

Publication Number Publication Date
ES2040217T3 true ES2040217T3 (es) 1993-10-16

Family

ID=13125083

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787103691T Expired - Lifetime ES2040217T3 (es) 1986-03-18 1987-03-14 Procedimiento para preparar derivados de acido flavona-carboxilico.

Country Status (7)

Country Link
US (2) US4831052A (es)
EP (1) EP0237986B1 (es)
JP (1) JPS62215581A (es)
AT (1) ATE67995T1 (es)
DE (1) DE3773415D1 (es)
ES (1) ES2040217T3 (es)
GR (1) GR3002832T3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0374789A1 (en) * 1988-12-19 1990-06-27 Kyowa Hakko Kogyo Co., Ltd. 5- Aminoflavone derivatives
US5194664A (en) * 1989-02-10 1993-03-16 Basf Aktiengesellschaft Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
DE3903992A1 (de) * 1989-02-10 1990-08-16 Basf Ag Aromatische ketoverbindungen, ihre herstellung und arzneimittel sowie kosmetika daraus
FR2661410B1 (fr) * 1990-04-27 1994-06-03 Caignard Daniel Nouveaux derives heterocycliques: 2-styryl 4h-1-benzopyrane-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993011755A1 (en) * 1991-12-18 1993-06-24 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
EP0619116A3 (en) * 1993-04-05 1994-11-23 Hoechst Japan Use of synthetic retinoids for osteopathy.
US5770382A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
US5770378A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
US5770383A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
WO1997012853A1 (en) 1995-10-06 1997-04-10 Ligand Pharmaceuticals Incorporated Dimer-selective rxr modulators and methods for their use
WO1999063980A1 (en) 1998-06-12 1999-12-16 Ligand Pharmaceuticals Inc. Treatment of anti-estrogen resistant breast cancer using rxr modulators
DE19918365A1 (de) * 1999-04-22 2000-10-26 Stefan Martens Genetische Sequenz, die für Flavonsynthase II Enzyme kodiert, und deren Verwendung
EP1212322A2 (en) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
SK2732002A3 (en) 1999-08-27 2002-07-02 Ligand Pharm Inc Androgen receptor modulator compounds and methods
WO2001019770A2 (en) 1999-09-14 2001-03-22 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
FR2815033B1 (fr) 2000-10-06 2003-09-05 Negma Lab Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
GB0915196D0 (en) 2009-09-01 2009-10-07 King S College London Therapeutic compounds and their use
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042192A (en) * 1962-07-10 1966-09-14 Benger Lab Ltd Furochromone compounds
GB1461777A (en) * 1973-06-08 1977-01-19 Fisons Ltd 2-phenyl-4-oxo-4h-1-benzopyran derivatives
LU69423A1 (es) * 1974-02-19 1975-12-09
FR2516922A1 (fr) * 1981-11-25 1983-05-27 Lipha Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant
FR2543140B1 (fr) * 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
EP0170105B1 (en) * 1984-07-07 1990-10-17 Koichi Prof. Dr. Shudo Benzoic acid derivatives
JPS6122046A (ja) * 1984-07-07 1986-01-30 Koichi Shiyudo スチルベン誘導体

Also Published As

Publication number Publication date
ATE67995T1 (de) 1991-10-15
EP0237986A3 (en) 1988-10-05
EP0237986A2 (en) 1987-09-23
JPH0255430B2 (es) 1990-11-27
US4925979A (en) 1990-05-15
US4831052A (en) 1989-05-16
EP0237986B1 (en) 1991-10-02
GR3002832T3 (en) 1993-01-25
JPS62215581A (ja) 1987-09-22
DE3773415D1 (de) 1991-11-07

Similar Documents

Publication Publication Date Title
ES2040217T3 (es) Procedimiento para preparar derivados de acido flavona-carboxilico.
ES2140391T3 (es) Derivados de dialcoxi-piridinil-bencimidazol, procedimiento para su preparacion y su uso farmaceutico.
AR245718A1 (es) Procedimiento para preparar un compuesto de imidazo (4,5-b)-piridina
ES480617A1 (es) Un procedimiento para la preparacion de n-(2-cloro-4-piridil)-ureas.
ES2028857T3 (es) Procedimiento para la preparacion de derivados de amino-tiazol y amino-oxazol.
DK0393493T3 (da) Fluorerede galdesyrederivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
EP0265514A4 (en) Drugs for the inhibition of ridicule.
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
MY101614A (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
ES8305764A1 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
ES2087854T3 (es) Nuevos oxatiolanos y derivados de los mismos, composiciones farmaceuticas que los contienen y el uso de los mismos como medicamentos.
HUT35238A (en) Process for producing diacyloxy-naphtalene derivatives of antipsoriatic activity and pharmaceutical compositions containing them as active agents
ES2140765T3 (es) Guanididas sustituidas del acido cinamico, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico cardiovascular, asi como medicamento que las contiene.
DE3775666D1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
ES2090374T3 (es) Derivados de tiazolina, procesos para su preparacion y composiciones plaguicidas que los contienen.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.
AR001995A1 (es) Derivados de bencisoxazol, procedimientos para su manufactura, agentes antiparasitarios que los contienen como ingredientes activos y procedimientospara el control de microorganismos fitopatogenicos, insectos y acaros.
DE3770321D1 (de) 1,5-benzothiazepinderivate, deren herstellung und deren verwendung in der therapie.
HUT61655A (en) Selective herbicide compositions containing salicylic acid derivatives as active components and process for producing the active components
AU7665187A (en) Diselenobis benzoic acid amides of primary heterocyclic amines, process for producing the same and pharmaceutical compounds comprising the same
FI832627A0 (fi) 7 -acyltio-15,16-metylen-3-oxo-17 -pregna-1,4-dien-21,17-karbolaktoner, foerfarande foer deras framstaellning och anvaendning som laekemedel
ES8607942A1 (es) Procedimiento para la obtencion de derivados de 3-(ureidociclohexilamino)-propan-1, 2-diol
AR009364A1 (es) PROCEDIMIENTO PARA LA SíNTESIS DE TETRAHIDROISOQUINOLINAS Y COMPUESTOS HETEROCíCLICOS RELACIONADOS.
MX9102192A (es) Mejoras en compuestos de piperazinoalquilbenzoxazina y piperazinoalquilbenzotiazin sustituidos con un heterociclo, asi como procedimiento para su preparacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 237986

Country of ref document: ES